Research on the impact of stem cell signaling on the development of mammary glands throws new light on the biology of breast tissue development and may point to new ways to diagnose and treat breast cancer.
NanoFlare nanotechnology enables biopsy-free diagnosis of skin disease and progression monitoring in response to therapy. It is a minimally-invasive, self-applied alternative that can reduce scarring and infection risks.
Adults with the most common form of pancreatic cancer with BRCA1 or BRCA2 gene mutations had better survival rates with platinum-based chemotherapy, compared with similar patients who received other drugs or no chemotherapy.
A computer program bpRNA that represents a key step toward better understanding the connections between mutant genetic material and disease has been developed. The software is a big-data annotation tool for secondary structures in ribonucleic acids
Patients with aggressive pancreatic cancer with BRCA1 and BRCA2 mutations who have few or no other treatment options can benefit from rucaparib drug. PARP inhibitor rucaparib was approved by FDA last month for the treatment of ovarian cancer
A new tool that can detect urine or urethral blockage is in the making and this technique can make it easier for patients to test themselves for the condition from the comfort of their own homes using their smart phones to record data.